Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

NICE recommends Pfizer’s dacomitinib for NSCLC patients

pharmaceutical-technologyJuly 09, 2019

Tag: Pfizer , NICE , NHS

PharmaSources Customer Service